On April 3rd, the Presidency of the Center for Technological Development and Innovation E.P.E. (CDTI) approved the 2024 Call for the NEOTEC program, with a maximum total amount of €20 million for this call aimed at innovative technology-based companies. The grants will be awarded through the CDTI, a Public Business Entity, attached to the Ministry of Science and Innovation. Additionally, within the available budget, a minimum amount of €5 million will be reserved for women-led companies.

The objective of this call is to highlight technology and innovation as competitive factors for company development. The call will finance new business projects from small companies that require the use of technologies or knowledge developed from research activity and where the business strategy is based on developing their own technology. Furthermore, emphasis will be placed on incorporating individuals with a doctorate into the company to enhance its capacity for absorption and generation of knowledge.   

  • Grants: as a non-repayable subsidy of up to 70% of the project’s budget / 85% if the proposal includes hiring doctors.
  • Minimum fundable budget: €175,000.
  • Maximum grant: €250,000 per beneficiary / €325,000 if the proposal includes hiring doctors.
  • Deadlines: starts on April 10, 2024, and ends on May 10, 2024.

Following the publication of the new call and given its importance and the interest generated in the sector, we at BIOVEGEN have prepared a report summarizing the main characteristics of the NEOTEC 2024 Call.